Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease.
- Author:
Sung Noh HONG
1
Author Information
- Publication Type:Review
- Keywords: Inflammatory bowel disease; Dysplasia; Endoscopic resection
- MeSH: Biopsy; Colectomy; Colorectal Neoplasms; Fibrosis; Humans; Inflammation; Inflammatory Bowel Diseases*; Intestinal Mucosa; Lymph Nodes; Neoplasm Metastasis; SNARE Proteins; Ulcer
- From:Clinical Endoscopy 2017;50(5):437-445
- CountryRepublic of Korea
- Language:English
- Abstract: Long-standing intestinal inflammation in patients with inflammatory bowel disease (IBD) induces dysplastic change in the intestinal mucosa and increases the risk of subsequent colorectal cancer. The evolving endoscopic techniques and technologies, including dye spraying methods and high-definition images, have been replacing random biopsies and have been revealed as more practical and efficient for detection of dysplasia in IBD patients. In addition, they have potential usefulness in detailed characterization of lesions and in the assessment of endoscopic resectability. Most dysplastic lesions without an unclear margin, definite ulceration, non-lifting sign, and high index of malignant change with suspicion for lymph node or distant metastases can be removed endoscopically. However, endoscopic resection of dysplasia in chronic IBD patients is usually difficult because it is often complicated by submucosal fibrosis. In patients with dysplasias that demonstrate submucosa fibrosis or a large size (≥20 mm), endoscopic submucosal dissection (ESD) or ESD with snaring (simplified or hybrid ESD) is an alternative option and may avoid a colectomy. However, a standardized endoscopic therapeutic approach for dysplasia in IBD has not been established yet, and dedicated specialized endoscopists with interest in IBD are needed to fully investigate recent emerging techniques and technologies.
